Latest filing published 27 Jan 2026 for Adicet Bio, Inc., €13k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Chen Schor in Adicet Bio, Inc. We count 23 filings; the first trade dates from 5 May 2021 and the latest from 24 January 2026.
On the market, this insider has only sold: 14 sales, €3.0M in total. Besides market trades, the filings include 8 share grants.
Most recently, on 27 January 2026, the filings show a share grant worth €13k in Adicet Bio, Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
23 of 23 declarations